{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T02:08:11Z","timestamp":1779156491175,"version":"3.51.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005565","name":"Johnson & Johnson Innovative Medicine","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Treating major depressive disorder is difficult due to the lack of objective criteria to guide therapy. Decision making often relies on trial and error, which limits treatment effectiveness. Precision psychiatry has been presented as a new approach that uses biological and multimodal data to support diagnosis and treatment, similar to precision medicine in other fields.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>This study aims to explore the perceptions of key experts regarding the drivers and barriers to the adoption of precision psychiatry in Latin America. Secondary objectives are to explore the conceptualization of precision psychiatry, explore its potential benefits in the context of MDD, identify potential drivers and barriers to its implementation in the region, and identify context specific considerations for future implementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a qualitative study based on interviews, and a hybrid deductive-inductive content analysis was applied. A scoping review informed the development of a semi structured interview guide. Semi structured interviews were then conducted with experts involved in healthcare provision, mental health policy shaping, and academic research. The interviews explored the perceived value of precision psychiatry, its potential contribution to the treatment of major depressive disorder, and the challenges surrounding its adoption in the region.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Participants viewed precision psychiatry as a promising approach to improve diagnostic accuracy, guide targeted treatment, and use healthcare resources more efficiently. These advantages were seen as particularly relevant for major depressive disorder due to its high burden, heterogeneity, and prevalence of treatment resistant cases in Latin America. Key barriers included limited understanding of precision concepts, insufficient evidence on effectiveness and cost, low provider awareness, high implementation costs, regulatory constraints, and systemic challenges such as under-resourced services, stigma, and shortages of trained professionals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Precision psychiatry has the potential to improve mental health care in Latin America according to participants, especially for major depressive disorder. Realizing this potential will require stronger evidence, greater investment in research and training, improved information systems, stronger mental health policies, and regulatory processes that can assess clinical, economic, and societal value. Coordinated efforts across stakeholders are necessary to support its development and adoption.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12888-026-08038-5","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T12:17:12Z","timestamp":1775218632000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Value drivers and barriers to the adoption of Precision Psychiatry in Latin America: a qualitative study"],"prefix":"10.1186","volume":"26","author":[{"given":"Margarita","family":"Quijano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Victor","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilary","family":"Felton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Ram\u00edrez-Berm\u00fadez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humberto","family":"Correa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Lopez","family":"Jaramillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Serretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"key":"8038_CR1","unstructured":"Bains N, Abdijadid S. Major Depressive Disorder [Internet]. 2023 [cited 2025 Jul 30]. Report. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559078\/"},{"key":"8038_CR2","unstructured":"PAHO. Leading causes of death, and disability [Internet]. 2023 [cited 2025 Jul 30]. Available from: https:\/\/www.paho.org\/en\/enlace\/leading-causes-death-and-disability"},{"issue":"4","key":"8038_CR3","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1007\/s11126-021-09930-x","volume":"92","author":"B Soares","year":"2021","unstructured":"Soares B, Kanevsky G, Teng CT, P\u00e9rez-Esparza R, Bonetto GG, Lacerda ALT, et al. Prevalence and Impact of Treatment-Resistant Depression in Latin America: a Prospective, Observational Study. Psychiatr Q. 2021;92(4):1797\u2013815. https:\/\/doi.org\/10.1007\/s11126-021-09930-x.","journal-title":"Psychiatr Q"},{"issue":"155","key":"8038_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.53680\/vertex.v33i155.134","volume":"33","author":"G Garc\u00eda Bonetto","year":"2022","unstructured":"Garc\u00eda Bonetto G, Corral RM, Lupo C, Vilapri\u00f1o Duprat M, Alessandria H, Kanevsky G, et al. Trastorno depresivo mayor y depresi\u00f3n resistente al tratamiento: un an\u00e1lisis epidemiol\u00f3gico en Argentina del estudio de Depresi\u00f3n resistente al tratamiento en Am\u00e9rica Latina. Vertex Revista Argentina de Psiquiatr\u00eda. 2022;33(155):36\u201349. https:\/\/doi.org\/10.53680\/vertex.v33i155.134.","journal-title":"Vertex Revista Argentina de Psiquiatr\u00eda"},{"issue":"3","key":"8038_CR5","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1590\/1516-4446-2013-1294","volume":"36","author":"MT Silva","year":"2014","unstructured":"Silva MT, Galvao TF, Martins SS, Pereira MG. Prevalence of depression morbidity among Brazilian adults: a systematic review and meta-analysis. Revista Brasileira de Psiquiatria. 2014;36(3):262\u201370. https:\/\/doi.org\/10.1590\/1516-4446-2013-1294.","journal-title":"Revista Brasileira de Psiquiatria"},{"key":"8038_CR6","unstructured":"Wagner FA, Gonz\u00e1lez\u2013Forteza C, S\u00e1nchez\u2013Garc\u00eda S, Garc\u00eda\u2013Pe\u00f1a C, Gallo JJ. Targeting depression as a public health problem in Mexico. Salud mental. 2012;35(1)."},{"issue":"7","key":"8038_CR7","doi-asserted-by":"publisher","first-page":"e036777","DOI":"10.1136\/bmjopen-2020-036777","volume":"10","author":"D Villarreal-Zegarra","year":"2020","unstructured":"Villarreal-Zegarra D, Cabrera-Alva M, Carrillo-Larco RM, Bernabe-Ortiz A. Trends in the prevalence and treatment of depressive symptoms in Peru: a population-based study. BMJ Open. 2020;10(7):e036777. https:\/\/doi.org\/10.1136\/bmjopen-2020-036777.","journal-title":"BMJ Open"},{"key":"8038_CR8","unstructured":"Bio DS, Souza \u00c9L, Moreno RA. Symptomatic remission and quality of life in patients with major depression treated with antidepressants: a prospective study. Aletheia [Internet]. 2011 [cited 2025 Jul 30];34. Available from: https:\/\/pepsic.bvsalud.org\/scielo.php?script=sci_arttext%26pid=S1413-03942011000100012%26lng=pt%26tlng=pt"},{"issue":"6","key":"8038_CR9","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1177\/2374373520958514","volume":"7","author":"O Robelo-Zarza","year":"2020","unstructured":"Robelo-Zarza O, Vargas-Huicochea I, Kelsall N, Rodr\u00edguez-Machain A. Suffering Depression: Illness Perception of Informal Primary Caregivers of Medical Students With Major Depressive Disorder. J Patient Exp. 2020;7(6):1577\u201388. https:\/\/doi.org\/10.1177\/2374373520958514.","journal-title":"J Patient Exp"},{"key":"8038_CR10","unstructured":"UNICEF. Over US$30 billion is lost to economies in Latin America and the Caribbean each year due to youth mental health disorders [Internet]. 2021 [cited 2025 Jul 30]. Available from: https:\/\/www.unicef.org\/lac\/en\/press-releases\/over-us30-billion-is-lost-to-economies-in-latin-america-and-caribbean-each-year-due-youth-mental-health-disorder"},{"issue":"1","key":"8038_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/13651501.2020.1809680","volume":"25","author":"R Zanardi","year":"2021","unstructured":"Zanardi R, Prestifilippo D, Fabbri C, Colombo C, Maron E, Serretti A. Precision psychiatry in clinical practice. Int J Psychiatry Clin Pract. 2021;25(1):19\u201327. https:\/\/doi.org\/10.1080\/13651501.2020.1809680.","journal-title":"Int J Psychiatry Clin Pract"},{"key":"8038_CR12","doi-asserted-by":"publisher","unstructured":"Tsermpini EE, Serretti A, Dol\u017ean V. Precision Medicine in Antidepressants Treatment. 2023;131\u201386. https:\/\/doi.org\/10.1007\/164_2023_654","DOI":"10.1007\/164_2023_654"},{"issue":"3","key":"8038_CR13","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.tins.2022.12.004","volume":"46","author":"H Hampel","year":"2023","unstructured":"Hampel H, Gao P, Cummings J, Toschi N, Thompson PM, Hu Y, et al. The foundation and architecture of precision medicine in neurology and psychiatry. Trends Neurosci. 2023;46(3):176\u201398. https:\/\/doi.org\/10.1016\/j.tins.2022.12.004.","journal-title":"Trends Neurosci"},{"key":"8038_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.euroneuro.2025.08.003","volume":"100","author":"NE Fares-Otero","year":"2025","unstructured":"Fares-Otero NE, Budde M, Laatsch J, Harrer M, Pelgrim T, Philipsen A, et al. Efficacy of pharmacogenetic (PGx)-guided antidepressant treatment on functional outcomes and quality of life in adults with anxiety and affective disorders: A systematic review and meta-analysis. Eur Neuropsychopharmacol. 2025;100:13\u201323. https:\/\/doi.org\/10.1016\/j.euroneuro.2025.08.003.","journal-title":"Eur Neuropsychopharmacol"},{"key":"8038_CR15","doi-asserted-by":"publisher","unstructured":"Serretti A. Precision medicine in mood disorders. Psychiatry Clin Neurosciences Rep. 2022;1(1). https:\/\/doi.org\/10.1002\/pcn5.1.","DOI":"10.1002\/pcn5.1"},{"issue":"1","key":"8038_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/07067437211037141","volume":"67","author":"JRA Benoit","year":"2022","unstructured":"Benoit JRA, Dursun SM, Greiner R, Cao B, Brown MRG, Lam RW, et al. Using Machine Learning to Predict Remission in Patients With Major Depressive Disorder Treated With Desvenlafaxine. Can J Psychiatry. 2022;67(1):39\u201347. https:\/\/doi.org\/10.1177\/07067437211037141.","journal-title":"Can J Psychiatry"},{"issue":"3","key":"8038_CR17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.rpsm.2015.03.003","volume":"8","author":"E Vieta","year":"2015","unstructured":"Vieta E. La medicina personalizada aplicada a la salud mental: la psiquiatr\u00eda de precisi\u00f3n. Rev Psiquiatr Salud Ment. 2015;8(3):117\u20138. https:\/\/doi.org\/10.1016\/j.rpsm.2015.03.003.","journal-title":"Rev Psiquiatr Salud Ment"},{"key":"8038_CR18","unstructured":"National Human Genome Research Institute. Precision Medicine [Internet]. 2026 [cited 2026 Feb 24]. Available from: https:\/\/www.genome.gov\/genetics-glossary\/Precision-Medicine"},{"issue":"1","key":"8038_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12916-017-0849-x","volume":"15","author":"BS Fernandes","year":"2017","unstructured":"Fernandes BS, Williams LM, Steiner J, Leboyer M, Carvalho AF, Berk M. The new field of \u2018precision psychiatry\u2019. BMC Med. 2017;15(1):80. https:\/\/doi.org\/10.1186\/s12916-017-0849-x.","journal-title":"BMC Med"},{"issue":"5\u20136","key":"8038_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11017-022-09558-3","volume":"42","author":"K Tabb","year":"2021","unstructured":"Tabb K, Lemoine M. The prospects of precision psychiatry. Theor Med Bioeth. 2021;42(5\u20136):193\u2013210. https:\/\/doi.org\/10.1007\/s11017-022-09558-3.","journal-title":"Theor Med Bioeth"},{"key":"8038_CR21","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.2147\/NDT.S337814","volume":"17","author":"E \u010ce\u0161kov\u00e1","year":"2021","unstructured":"\u010ce\u0161kov\u00e1 E, \u0160ilh\u00e1n P. From Personalized Medicine to Precision Psychiatry? Neuropsychiatr Dis Treat. Volume. 2021;17:3663\u20138. https:\/\/doi.org\/10.2147\/NDT.S337814.","journal-title":"Volume"},{"issue":"9","key":"8038_CR22","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1017\/S0033291720005309","volume":"51","author":"E Salagre","year":"2021","unstructured":"Salagre E, Vieta E. Commentary on Kohne and van OS view on precision psychiatry. Psychol Med. 2021;51(9):1412\u20134. https:\/\/doi.org\/10.1017\/S0033291720005309.","journal-title":"Psychol Med"},{"issue":"5","key":"8038_CR23","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S2215-0366(15)00579-9","volume":"3","author":"LM Williams","year":"2016","unstructured":"Williams LM. Precision psychiatry: a neural circuit taxonomy for depression and anxiety. Lancet Psychiatry. 2016;3(5):472\u201380. https:\/\/doi.org\/10.1016\/S2215-0366(15)00579-9.","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"8038_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357. https:\/\/doi.org\/10.1093\/intqhc\/mzm042.","journal-title":"Int J Qual Health Care"},{"key":"8038_CR25","unstructured":"The World Bank. The World by income and region [Internet]. 2024 [cited 2026 Feb 24]. Available from: https:\/\/datatopics.worldbank.org\/world-development-indicators\/the-world-by-income-and-region.html"},{"key":"8038_CR26","doi-asserted-by":"publisher","first-page":"114523","DOI":"10.1016\/j.socscimed.2021.114523","volume":"292","author":"M Hennink","year":"2022","unstructured":"Hennink M, Kaiser BN. Sample sizes for saturation in qualitative research: A systematic review of empirical tests. Soc Sci Med. 2022;292:114523. https:\/\/doi.org\/10.1016\/j.socscimed.2021.114523.","journal-title":"Soc Sci Med"},{"key":"8038_CR27","doi-asserted-by":"publisher","unstructured":"Guest G, Bunce A, Johnson L. How Many Interviews Are Enough? Field methods. 2006;18(1):59\u201382. https:\/\/doi.org\/10.1177\/1525822X05279903.","DOI":"10.1177\/1525822X05279903"},{"issue":"1","key":"8038_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13012-022-01245-0","volume":"17","author":"LJ Damschroder","year":"2022","unstructured":"Damschroder LJ, Reardon CM, Widerquist MAO, Lowery J. The updated Consolidated Framework for Implementation Research based on user feedback. Implement Sci. 2022;17(1):75. https:\/\/doi.org\/10.1186\/s13012-022-01245-0.","journal-title":"Implement Sci"},{"issue":"1","key":"8038_CR29","doi-asserted-by":"publisher","first-page":"11078","DOI":"10.1038\/s41467-025-67448-3","volume":"16","author":"A Ib\u00e1\u00f1ez","year":"2025","unstructured":"Ib\u00e1\u00f1ez A, Duran-Aniotz C, Migeot J, B\u00e1ez S, Fittipaldi S, Coronel-Oliveros C, et al. Computational whole-body-exposome models for global precision brain health. Nat Commun. 2025;16(1):11078. https:\/\/doi.org\/10.1038\/s41467-025-67448-3.","journal-title":"Nat Commun"},{"issue":"11","key":"8038_CR30","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1177\/0004867418805210","volume":"52","author":"S Henderson","year":"2018","unstructured":"Henderson S, Boyce P. Landscapes of tomorrow: Precision psychiatry and beyond. Australian New Z J Psychiatry. 2018;52(11):1015\u20138. https:\/\/doi.org\/10.1177\/0004867418805210.","journal-title":"Australian New Z J Psychiatry"},{"issue":"6","key":"8038_CR31","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1038\/s41380-024-02846-5","volume":"30","author":"S Mesens","year":"2025","unstructured":"Mesens S, Kezic I, Van Der Ark P, Etropolski M, Pandina G, Benes H, et al. Treatment effect and safety of seltorexant as monotherapy for patients with major depressive disorder: a randomized, placebo-controlled clinical trial. Mol Psychiatry. 2025;30(6):2427\u201335. https:\/\/doi.org\/10.1038\/s41380-024-02846-5.","journal-title":"Mol Psychiatry"},{"key":"8038_CR32","unstructured":"Healio, MDD [Internet]. Aticaprant shows symptom improvement as adjunctive treatment in. 2023 [cited 2025 Jul 30]. Available from: https:\/\/www.healio.com\/news\/psychiatry\/20230531\/aticaprant-shows-symptom-improvement-as-adjunctive-treatment-in-mdd"},{"key":"8038_CR33","unstructured":"Pharmaceutical Technology. Daridorexant hydrochloride by Idorsia Pharmaceutical for Post-Traumatic Stress Disorder (PTSD): Likelihood of Approval [Internet]. 2025 [cited 2025 Jul 30]. Available from: https:\/\/www.pharmaceutical-technology.com\/data-insights\/daridorexant-hydrochloride-idorsia-pharmaceutical-post-traumatic-stress-disorder-ptsd-likelihood-of-approval\/?utm_source=lgp5-loa%26utm_medium=24-212664%26utm_campaign=recommended-articles-pi"},{"key":"8038_CR34","unstructured":"Pharmaceutical Technology. Ropanicant by Suven Life Sciences for Major Depressive Disorder: Likelihood of Approval [Internet]. 2024 [cited 2025 Jul 30]. Available from: https:\/\/www.pharmaceutical-technology.com\/data-insights\/ropanicant-suven-life-sciences-major-depressive-disorder-likelihood-of-approval\/"},{"key":"8038_CR35","unstructured":"Pharmaceutical Technology. Risk adjusted net present value: What is the current valuation of Novartis\u2019s Onfasprodil? [Internet]. 2024 [cited 2025 Jul 30]. Available from: https:\/\/www.pharmaceutical-technology.com\/data-insights\/onfasprodil-novartis-net-present-value-2\/"},{"key":"8038_CR36","unstructured":"Pharmaceutical Technology. Risk adjusted net present value: What is the current valuation of Neumora Therapeutics\u2019s Navacaprant? [Internet]. 2024 [cited 2025 Jul 30]. Available from: https:\/\/www.pharmaceutical-technology.com\/data-insights\/navacaprant-neumora-therapeutics-net-present-value\/?cf-view"},{"key":"8038_CR37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.euroneuro.2021.10.771","volume":"55","author":"A Martinez-Aran","year":"2022","unstructured":"Martinez-Aran A, Vieta E. Precision psychotherapy. Eur Neuropsychopharmacol. 2022;55:20\u20131. https:\/\/doi.org\/10.1016\/j.euroneuro.2021.10.771.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"8038_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/br.2017.922","volume":"7","author":"S Mathur","year":"2017","unstructured":"Mathur S, Sutton J. Personalized medicine could transform healthcare. Biomed Rep. 2017;7(1):3\u20135. https:\/\/doi.org\/10.3892\/br.2017.922.","journal-title":"Biomed Rep"},{"issue":"8","key":"8038_CR39","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.jval.2022.01.006","volume":"25","author":"H Vellekoop","year":"2022","unstructured":"Vellekoop H, Versteegh M, Huygens S, Corro Ramos I, Szilberhorn L, Zelei T, et al. The Net Benefit of Personalized Medicine: A Systematic Literature Review and Regression Analysis. Value Health. 2022;25(8):1428\u201338. https:\/\/doi.org\/10.1016\/j.jval.2022.01.006.","journal-title":"Value Health"},{"key":"8038_CR40","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2147\/PGPM.S198225","volume":"13","author":"M Manchia","year":"2020","unstructured":"Manchia M, Pisanu C, Squassina A, Carpiniello B. Challenges and Future Prospects of Precision Medicine in Psychiatry. Pharmgenomics Pers Med. 2020;13:127\u201340. https:\/\/doi.org\/10.2147\/PGPM.S198225.","journal-title":"Pharmgenomics Pers Med"},{"key":"8038_CR41","doi-asserted-by":"publisher","unstructured":"Reger GM, McClure M, Lou, Ruskin D, Carter SP, Reger MA. Integrating Predictive Modeling Into Mental Health Care: An Example in Suicide Prevention. 2019;70(1):71\u20134. https:\/\/doi.org\/10.1176\/appi.ps.201800242","DOI":"10.1176\/appi.ps.201800242"},{"issue":"11","key":"8038_CR42","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/abm\/kaaa018","volume":"54","author":"E Hekler","year":"2020","unstructured":"Hekler E, Tiro JA, Hunter CM, Nebeker C. Precision Health: The Role of the Social and Behavioral Sciences in Advancing the Vision. Ann Behav Med. 2020;54(11):805\u201326. https:\/\/doi.org\/10.1093\/abm\/kaaa018.","journal-title":"Ann Behav Med"},{"key":"8038_CR43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.euroneuro.2022.08.001","volume":"63","author":"P Fusar-Poli","year":"2022","unstructured":"Fusar-Poli P, Manchia M, Koutsouleris N, Leslie D, Woopen C, Calkins ME, et al. Ethical considerations for precision psychiatry: A roadmap for research and clinical practice. Eur Neuropsychopharmacol. 2022;63:17\u201334. https:\/\/doi.org\/10.1016\/j.euroneuro.2022.08.001.","journal-title":"Eur Neuropsychopharmacol"},{"key":"8038_CR44","unstructured":"Latin America Genomics Consortium. Advancing Psychiatric Genomics in Latin American Populations [Internet]. 2023 [cited 2025 Jul 30]. Available from: https:\/\/latinamericangenomicsconsortium.org\/"},{"key":"8038_CR45","unstructured":"Ministry of Science Technology and Innovation of Argentina. Poblar [Internet]. 2023 [cited 2025 Jul 30]. Available from: https:\/\/www.argentina.gob.ar\/ciencia\/seppCTI\/poblar"},{"key":"8038_CR46","unstructured":"Ministry of Human Rights and Citizenship. Governo Federal lan\u00e7a programa in\u00e9dito de medicina de precis\u00e3o [Internet]. 2020 [cited 2024 Jul 4]. Available from: https:\/\/www.gov.br\/mdh\/pt-br\/assuntos\/noticias\/2020-2\/outubro\/governo-federal-lanca-programa-inedito-de-medicina-de-precisao"},{"key":"8038_CR47","unstructured":"Pulzo, \u2018Origen\u2019., el proyecto que busca cambiar el sistema de salud con la medicina preventiva [Internet]. 2022 [cited 2025 Jul 30]. Available from: https:\/\/www.pulzo.com\/vivir-bien\/proyecto-origen-genoma-humano-colombia-que-trata-primer-piloto-PP2252603"},{"key":"8038_CR48","doi-asserted-by":"publisher","first-page":"100627","DOI":"10.1016\/j.lana.2023.100627","volume":"28","author":"WD Dawson","year":"2023","unstructured":"Dawson WD, Booi L, Pintado-Caipa M, Okada de Oliveira M, Kornhuber A, Spoden N, et al. The Brain Health Diplomat\u2019s Toolkit: supporting brain health diplomacy leaders in Latin America and the Caribbean. Lancet Reg Health - Americas. 2023;28:100627. https:\/\/doi.org\/10.1016\/j.lana.2023.100627.","journal-title":"Lancet Reg Health - Americas"},{"key":"8038_CR49","doi-asserted-by":"publisher","first-page":"101322","DOI":"10.1016\/j.lana.2025.101322","volume":"54","author":"J Ram\u00edrez-Berm\u00fadez","year":"2026","unstructured":"Ram\u00edrez-Berm\u00fadez J, Castro-Suarez S, D\u2019Alessio L, Holgu\u00edn Lew J, Makarem Oliveira L, Sanches Yassuda M, et al. Towards a Latin American neuropsychiatry: challenges and opportunities. Lancet Reg Health - Americas. 2026;54:101322. https:\/\/doi.org\/10.1016\/j.lana.2025.101322.","journal-title":"Lancet Reg Health - Americas"},{"issue":"5","key":"8038_CR50","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2217\/pme-2020-0049","volume":"17","author":"A Panduro","year":"2020","unstructured":"Panduro A, Roman S. Personalized Medicine in Latin America. Per Med. 2020;17(5):339\u201343. https:\/\/doi.org\/10.2217\/pme-2020-0049.","journal-title":"Per Med"},{"issue":"7","key":"8038_CR51","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3390\/brainsci12070934","volume":"12","author":"H Baldwin","year":"2022","unstructured":"Baldwin H, Loebel-Davidsohn L, Oliver D, Salazar de Pablo G, Stahl D, Riper H, et al. Real-World Implementation of Precision Psychiatry: A Systematic Review of Barriers and Facilitators. Brain Sci. 2022;12(7):934. https:\/\/doi.org\/10.3390\/brainsci12070934.","journal-title":"Brain Sci"},{"issue":"1","key":"8038_CR52","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.cell.2019.01.015","volume":"177","author":"PF Sullivan","year":"2019","unstructured":"Sullivan PF, Geschwind DH. Defining the Genetic, Genomic, Cellular, and Diagnostic Architectures of Psychiatric Disorders. Cell. 2019;177(1):162\u201383. https:\/\/doi.org\/10.1016\/j.cell.2019.01.015.","journal-title":"Cell"},{"key":"8038_CR53","doi-asserted-by":"publisher","unstructured":"G\u00f3mez-Carrillo A, Paquin V, Dumas G, Kirmayer LJ. Restoring the missing person to personalized medicine and precision psychiatry. Front Neurosci. 2023;17. https:\/\/doi.org\/10.3389\/fnins.2023.1041433.","DOI":"10.3389\/fnins.2023.1041433"},{"issue":"9","key":"8038_CR54","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/0004867419849482","volume":"53","author":"F Stiefel","year":"2019","unstructured":"Stiefel F, Conus P, Bourquin C, Australian. New Z J Psychiatry. 2019;53(9):841\u20133. https:\/\/doi.org\/10.1177\/0004867419849482.","journal-title":"New Z J Psychiatry"},{"key":"8038_CR55","doi-asserted-by":"publisher","first-page":"105697","DOI":"10.1016\/j.neubiorev.2024.105697","volume":"162","author":"J Migeot","year":"2024","unstructured":"Migeot J, Panesso C, Duran-Aniotz C, \u00c1vila-Rinc\u00f3n C, Ochoa C, Huepe D, et al. Allostasis, health, and development in Latin America. Neurosci Biobehav Rev. 2024;162:105697. https:\/\/doi.org\/10.1016\/j.neubiorev.2024.105697.","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"8038_CR56","doi-asserted-by":"publisher","first-page":"5","DOI":"10.7705\/biomedica.6996","volume":"43","author":"DA Forero","year":"2023","unstructured":"Forero DA. Genomics of psychiatric disorders: Regional challenges and opportunities. Biom\u00e9dica. 2023;43(1):5\u20137. https:\/\/doi.org\/10.7705\/biomedica.6996.","journal-title":"Biom\u00e9dica"},{"issue":"2","key":"8038_CR57","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/2159676X.2019.1704846","volume":"13","author":"V Braun","year":"2021","unstructured":"Braun V, Clarke V. To saturate or not to saturate? Questioning data saturation as a useful concept for thematic analysis and sample-size rationales. Qual Res Sport Exerc Health. 2021;13(2):201\u201316. https:\/\/doi.org\/10.1080\/2159676X.2019.1704846.","journal-title":"Qual Res Sport Exerc Health"},{"issue":"5","key":"8038_CR58","doi-asserted-by":"publisher","first-page":"e0232076","DOI":"10.1371\/journal.pone.0232076","volume":"15","author":"G Guest","year":"2020","unstructured":"Guest G, Namey E, Chen M. A simple method to assess and report thematic saturation in qualitative research. PLoS ONE. 2020;15(5):e0232076. https:\/\/doi.org\/10.1371\/journal.pone.0232076.","journal-title":"PLoS ONE"},{"issue":"1","key":"8038_CR59","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/0706743721998044","volume":"67","author":"IC Passos","year":"2022","unstructured":"Passos IC, Ballester P, Rabelo-da-Ponte FD, Kapczinski F. Precision Psychiatry: The Future Is Now. Can J Psychiatry. 2022;67(1):21\u20135. https:\/\/doi.org\/10.1177\/0706743721998044.","journal-title":"Can J Psychiatry"},{"key":"8038_CR60","doi-asserted-by":"publisher","unstructured":"Comai S, Manchia M, Bosia M, Miola A, Poletti S, Benedetti F, et al. Moving toward precision and personalized treatment strategies in psychiatry. Int J Neuropsychopharmacol. 2025;28(5). https:\/\/doi.org\/10.1093\/ijnp\/pyaf025.","DOI":"10.1093\/ijnp\/pyaf025"},{"key":"8038_CR61","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.euroneuro.2024.02.001","volume":"84","author":"N Lorenzon","year":"2024","unstructured":"Lorenzon N, Dierssen M. Diving into the precision psychiatry debate: How deep can we go? Eur Neuropsychopharmacol. 2024;84:57\u20138. https:\/\/doi.org\/10.1016\/j.euroneuro.2024.02.001.","journal-title":"Eur Neuropsychopharmacol"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-026-08038-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08038-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08038-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T01:52:56Z","timestamp":1779155576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-026-08038-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8038"],"URL":"https:\/\/doi.org\/10.1186\/s12888-026-08038-5","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received ethical approval from the Research Ethics Committee CAIMED, Centro de Atenci\u00f3n e Investigaci\u00f3n M\u00e9dica (\n                      Center for Medical Care and Research\n                      ), Colombia, in March 2025, under the code (N\u00b0 CEIC-01440-25). The CAIMED Research Ethics Committee operates in accordance with the country\u2019s legal and ethical guidelines as established by Resolutions 008430 of 1993 and 002378 of 2008 of the Ministry of Social Protection of Colombia, as well as international guidelines: Nuremberg Code, Declaration of Helsinki (World Medical Association, 1964) and its subsequent revisions, Belmont Report, Universal Declaration on Bioethics and Human Rights (UNESCO, 2005), among other national and international regulations described in its statutes on biomedical research. The study was performed according to ethical principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All subjects received written information and gave written consent to participate in the study and for publication of data before the interviews started. Participants consent to have their responses to be used in the study without direct attribution.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"406"}}